May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Angiotensin II Mediates Retinal Leukostasis in Diabetic Rats
Author Affiliations & Notes
  • P. Chen
    Eye Care Services Research, Henry Ford Health System, Detroit, MI, United States
  • G.M. Scicli
    Eye Care Services Research, Henry Ford Health System, Detroit, MI, United States
  • D. Dahl
    Eye Care Services Research, Henry Ford Health System, Detroit, MI, United States
  • P.A. Edwards
    Eye Care Services Research, Henry Ford Health System, Detroit, MI, United States
  • A.G. Scicli
    Eye Care Services Research, Henry Ford Health System, Detroit, MI, United States
  • Footnotes
    Commercial Relationships  P. Chen, None; G.M. Scicli, None; D. Dahl, None; P.A. Edwards, None; A.G. Scicli, None.
  • Footnotes
    Support  AHA 0225527Z
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3896. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Chen, G.M. Scicli, D. Dahl, P.A. Edwards, A.G. Scicli; Angiotensin II Mediates Retinal Leukostasis in Diabetic Rats . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3896.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To determine whether suppressing the activity of the endogenous renin angiotensin system affects diabetic retinal leukostasis. Methods:Rats with streptozotocin-induced diabetes (6-8/group, glycemia ≥250 mg/dl,) were treated with an ACE inhibitor (ramipril) or with an Angiotensin II AT1 receptor antagonist (losartan). We also tested the effect of a Ca channel blocker, Nifedipine. Two weeks after diabetes induction, the rats were examined for retinal leukostasis using a scanning laser ophthalmoscope. Leukocytes were labeled with acridine orange. Dextran- fluorescein was used to define the relationship of static leukocytes with the retinal microcirculation. Arrested leukocytes were defined as cells that were observed static in the retina for at least 3 min. Leukocyte-induced capillary non-perfusion was defined as capillaries that show no perfusion for at least 2 min, apparently due to a trapped static leukocyte. Leukostasis was expressed as 10-5cells/pixels2. Results:Retinal leukostasis was markedly higher in diabetic rats compared with normal controls: 4.4±0.5 vs. 0.13±0.08; p< 0.05. Treatment with either ramipril or losartan significantly decreased leukostasis: 1.4±0.16 and 1.3±0.14 respectively; p< 0.05 vs. untreated diabetic rats. Leukocyte-induced capillary nonperfusion was not observed in normal control rats. It was 0.75±0.26 in untreated diabetic rats, and it was significantly decreased in rats treated with either ramipril or losartan: 0.18±0.18 and 0.15±0.29 respectively; p< 0.05 vs untreated. Nifedipine treatment did not result in significant changes in either retinal leukostasis or capillary nonperfusion. All treatments induced similar (~16 mm Hg) decreases in systolic blood pressure. Conclusions: Suppressing the activity of the endogenous renin angiotensin system markedly decreases the retinal leukostasis and capillary nonperfusion that occurs after the onset of type I diabetes in rats. These effects are not dependent on blood pressure changes. Angiotensin II may mediate retinal leukostasis in early diabetes.

Keywords: diabetic retinopathy • retina • diabetes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×